·   Log in

‘Pharma’ News

Sun Pharma gets US nod for Nicardipine Hydrochloride Injections (HCI) for hypertension

Thursday, November 19, 2009 20:27

Mumbai: Sun Pharmaceutical Industries Limited, based in India, has received final approval from the United States Food and Drug Administration (FDA) for the company’s application for Nicardipine Hydrochloride Injections (HCI), which is a short-term treatment for hypertension.

Tagged with: , ,

Daiichi-Ranbaxy to supply Nuvo’s wound healing agent Oxoferin in Asian countries

Friday, November 13, 2009 15:41

Daiichi-Ranbaxy has tied up with Canada-based transdermal drug development firm Nuvo Research Inc to supply a topical wound healing agent Oxoferin in some Asian countries.

Tagged with: ,

One-a-day epilepsy pill eslicarbazepine acetate (Zebinix) launched in UK

Wednesday, November 11, 2009 19:47

Eslicarbazepine acetate (Zebinix), a once-daily pill to treat epileptic seizures  by Eisai has been launched in UK.

Wyeth suspends Prevnar pneumococcal vaccine batch following deaths of infants in The Netherlands

Friday, November 6, 2009 13:21

Wyeth's Prevnar vaccine trials were suspended in India last year after reports of infant death

Ranbaxy honours scientists & young scholars in pharma and medicine research

Thursday, November 5, 2009 15:14

Ranbaxy Science Foundation (RSF), a non-profit organization set-up by Ranbaxy Laboratories Limited (RLL), has honoured Indian researchers in pharma and medicine for their outstanding contributions in its 21st Annual Research Awards for the year 2008

Tagged with:

Novartis expands R&D operations in China; to invest $1 bn in 5 years

Tuesday, November 3, 2009 19:21

Swiss drug major Novartis AG is increase its research and development activities in China by investing a USD 1 billion investment over the next five years, the company said in a press release.

Tagged with: ,

Six Indian pharma companies may face product ban in Sri Lanka for marketing ‘contaminated’ drugs

Friday, October 30, 2009 12:50

Six Indian companies are facing the risk of getting blacklisted and their products banned in Sri Lankan pharmaceutical market for allegedly marketing contaminated drug products including vaccines.

Tagged with: ,

Intravenous (IV) H1N1 swine flu drug peramivir approved for emergency use in US: Biocryst

Monday, October 26, 2009 13:39

Intravenous (IV) H1N1 swine flu drug peramivir from BioCryst Pharmaceuticals, Inc. has been given approval to use in emergencies by US FDA.

Tagged with: ,

Endo’s testosterone gel Fortesta to enhance sexual libido in men needs more data: US FDA

Thursday, October 22, 2009 17:38

Testosterone gel Fortesta to enhance sexual libido in testostrone deficient men by Endo Pharmaceuticals Holdings Inc has been delayed approval in US.

Novartis’ indacaterol (QAB149) to treat COPD needs more data on dosing: US FDA

Tuesday, October 20, 2009 20:22

Indacaterol (QAB149) has already received a positive regulatory opinion in Europe

Tagged with: ,